Adaptimmune Therapeutics shares owned by HighMark Wealth Management
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by HighMark Wealth Management
from 13F filings
Historical chart of HighMark Wealth Management investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by HighMark Wealth Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by HighMark Wealth Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $36 | 287 | 0.13 |
| 2025-06-30 | $68 | 287 | 0.24 |
| 2025-03-31 | $56 | 287 | 0.20 |
| 2024-12-31 | $155 | 287 | 0.54 |
| 2024-09-30 | $272 | 287 | 0.95 |
| 2024-06-30 | $279 | 287 | 0.98 |
| 2024-03-31 | $453 | 287 | 1.58 |
| 2023-12-31 | $227 | 287 | 0.79 |
| 2023-09-30 | $224 | 287 | 0.78 |
| 2023-06-30 | $1.2k | 1.3k | 0.93 |
More positions owned by HighMark Wealth Management
View all positions for HighMark Wealth Management